Company profile: Upperton Pharma Solutions
1.1 - Company Overview
Company description
- Provider of pharmaceutical contract development and manufacturing services for biotech and pharma, offering formulation development (powders, capsules, tablets) from feasibility to clinical manufacture; Phase 1–3 clinical supply; process scale-up and optimisation; registration activities; analytical development and validation; and UpperNose, a nasal product development platform for small and mid-sized innovators.
Products and services
- Process Scale-Up and Optimisation: Upperton engineers scale-up for larger batch sizes, optimises production parameters, and prepares processes for GMP transfer with GMP-transfer-ready protocols supporting development studies
- Formulation Development: Upperton architects drug formulations from early feasibility to clinical manufacture, developing oral solid dosage forms—powders, capsules, tablets—with custom-engineered processes tailored to biotechnology and pharmaceutical applications
- Phase 1 to Phase 3 Clinical Supply: Upperton produces and delivers trial materials across Phases 1–3, ensuring suitability for human testing with phase-specific production and supply practices
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Upperton Pharma Solutions
NeuroTrax
HQ: United States
Website
- Description: Provider of BrainCare, a cloud-based brain wellness assessment platform offering tests across seven cognitive areas, graphical reports for clinicians to track baselines and progress, and personalized activity and brain training recommendations, plus a 30-minute Post COVID Testing Suite evaluating memory, executive function, attention, and information processing speed for post-COVID cognitive assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroTrax company profile →
Letoon
HQ: United Kingdom
Website
- Description: Provider of ultrasonic extraction technology to convert vegetable waste and plant matter into high-value nutrients and ingredients, including lycopene recovery from tomato waste, serving the pharmaceutical, nutraceutical, cosmetic, and food sectors. Activities include production of high-value commodities, mergers and acquisitions, and research partnerships with Italian universities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Letoon company profile →
Nexelis
HQ: United States
Website
- Description: Provider of assay development and advanced laboratory testing; a portfolio company of Ampersand Capital Partners.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nexelis company profile →
Chiltern
HQ: United States
Website
- Description: Provider of clinical development, scientific services, and collaborative technologies for pharmaceutical and biotech companies as a contract research organization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chiltern company profile →
Modality Solutions
HQ: United States
Website
- Description: Provider of package engineering and controlled-environment logistics solutions for highly regulated industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modality Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Upperton Pharma Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Upperton Pharma Solutions
2.2 - Growth funds investing in similar companies to Upperton Pharma Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Upperton Pharma Solutions
4.2 - Public trading comparable groups for Upperton Pharma Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →